News

Cupron® Performance Additives Unveils Groundbreaking “Clear” Liquid Copper Platform for Sustainable Microbial Control Applications

Cupron Performance Additives (Cupron) today announced the launch of Cupron Clear™ — a revolutionary new liquid microbial copper platform. Cupron Clear™ is a transparent, stable, and highly efficacious liquid form of copper, designed for broad use across polymers and liquids. This new breakthrough delivers unmatched microbial control while exceeding modern standards for sustainability, economics, and safety.

Cupron Clear™ reinvents the chemistry of copper-based additives for liquid products, delivering over a hundred times the effectiveness of conventional copper solutions. With its innovative clear liquid format, Cupron Clear™ out-performs incumbent additives such as QUATs and Isothiazolinones, many of which are facing growing regulatory pressure. Cupron Clear™ sets a new standard for broad-spectrum efficacy against microorganisms. This next-generation technology provides end market and downstream users with a more sustainable, versatile, and high-performing copper-based biocide than ever before.

“This new liquid copper platform addresses the frustrations for so many different industries and dramatically expands the applications that can enjoy the benefits of Cupron innovations,” said Chris Andrews, CEO of Cupron. “It’s the direct result of focused R&D and our belief that economic, safer, sustainable technologies should replace legacy materials that no longer meet regulatory or performance standards.”

Representing a major leap forward in copper-based technologies, Cupron Clear™ is a first-to-market solution for personal care, hygiene, building & construction, textiles, plastics, paints and other coatings, adhesives, sealants, elastomers (C.A.S.E.) markets in need of the highest-performing form of cuprous copper in a colorless, liquid format.

“With the addition of Cupron Clear™ to the company’s product portfolio, we can now offer our partners unparalleled flexibility in manufacturing and application with a comprehensive suite of platforms across solid, dispersion and solution-based applications,” Andrews added.

In addition to securing patents and intellectual property rights across composition, process, and applications of Cupron Clear™, Cupron is already in discussion with global partners and distributors to deploy it across core markets.

Read more here.

Recent News

10/27/2025

Virginia can lead biotech manufacturing renaissance – if policymakers help

Last week, pharmaceutical giant Merck broke ground on a new $3 billion facility in Virginia that will create 8,000 construction jobs and 500 permanent manufacturing jobs. The new 400,000 square-foot, state-of-the-art plant isn’t merely the latest addition to Virginia’s rapidly growing biotech industry footprint. It’s a sign that America is making quick progress towards President

10/22/2025

Virginia Catalyst Announces Round 19 of Grant Funding

The Virginia Catalyst announced today that it is accepting letters of intent (LOI) for Grant Round 19 to fund the development and commercialization of life science projects that address major unmet needs for improving human health and advance Virginia’s economy. “We at the Virginia Catalyst are pleased to provide funding in support of the Governor’s

10/21/2025

SRI multi-party team selected as an awardee by ARPA-H to develop at-home screening for ≥30 types of cancers

SRI, along with research partners Foothold Labs and Triple Ring Technologies and commercial partner Beacon Dx Health, has been awarded up to $34 million from the Advanced Research Projects Agency for Health (ARPA-H) to develop technology as part of the POSEIDON (Platform Optimizing SynBio for Early Intervention and Detection in Oncology) program. This pioneering program